ARTICLE | Company News
CyDex, University of Kansas deal
August 9, 2010 7:00 AM UTC
CyDex received exclusive, worldwide rights to the university's sulfoalkyl ether-alkyl ether cyclodextrin derivative for CyDex's Captisol sulfobutylether beta-cyclodextrin technology portfolio. The tec...